Drugs
Firms Accused Of Profiteering By
Raising Prices
By One Thousand Percent
Drugs companies making everyday
medicines for
the NHS are facing claims of
profiteering
after imposing huge price rises for
commonly
prescribed drugs. The increases – some
as
high as 1,000 per cent in just two
years –
coincided with some of the firms
involved
earning massive profits. One company
boss said
the NHS ‘doesn’t care what it costs’.
The medicines are not new innovative
products
developed by pharmaceutical companies
after
enormous investment in research and
development. Instead, they are
unbranded
so-called ‘generic’ drugs which have
been
available for many years and include
commonly
used antibiotics prescribed to
millions of
patients. Last night, The Mail on
Sunday
investigation prompted the Department
of
Health to reveal it had launched a
review of
the price increases and to say that it
was
examining what action could be taken
against
manufacturers deemed to be making
excess
profits